Take an educational journey into the re-emerging world of psychedelic therapies with

Breakthrough Psychedelics

Three psychedelic substances including MDMA, psilocybin, and ketamine have been given breakthrough designations in clinical trial approval processes by the Food and Drug Administration (FDA). These three psychedelics represent three distinct 'classes' of psychedelics: phenethylamines (MDMA), tryptamines (psilocybin), and arylcyclohexylamines (ketamine). Ketamine has since been legally approved with MDMA and psilocybin projected for approval in the near future. This course aims to introduce persons to the clinical science, pharmacology, and use context of 'breakthrough psychedelics'.

Teachings are appropriate for healthcare professionals as well as the general public. Healthcare professionals will be able to incorporate the information offered in this program in ways beneficial to clients or patients.

Course Syllabus by Sections and Modules

The course is structured into six sections and further sub-divided into bite size modules ranging from 5-30 minutes each, allowing the learner to take things piece by piece or cover several at a time. The course equates to approximately 7 hours of online home study for completion.

What are Psychedelics
Breakthrough Psychedelics
Psychedelics and Mental Illness
Psychedelics and Physical Illness
Psychedelic Neurobiology
Introduction to Use Context

Core Principles
Pharmacodynamics
Pharmacokinetics
Drug Interaction
Tolerance and Addiction Potential

Introduction to MDMA
Pharmacodynamics and Mechanism of Action
Pharmacokinetics and Metabolism
Potential Uses and Indications
Safety and Adverse Effects
Toxicology of Ecstasy
Drug Interaction Potential

Introduction to Psilocybin
Pharmacodynamics and Mechanism of Action
Pharmacokinetics and Metabolism
Mystical Experience
Potential Uses and Indications
Safety and Adverse Effects
Drug Interaction Potential

Introduction to Ketamine
Pharmacodynamics and Mechanism of Action
Pharmacokinetics and Metabolism
Potential Uses and Indications
Safety and Adverse Effects
Drug Interaction Potential

Comparative Pharmacology: MDMA, Psilocybin, Ketamine
Designing a Healing Path
Self or Home Use
Ritual Use
Psychedelic Assisted Therapy
The Psychedelic - Psychotropic Interface
Combinations of MDMA, Psilocybin, and Ketamine

Course Design

This is an online course. Course materials are drawn from primary - tertiary scientific literature. The course is designed both with overall learning objectives as well as section specific learning objectives. You may download the course syllabus to view these. Watch on your desktop at home or download the Kajabi app to access your course on a mobile device.

Download Course Syllabus

Get Started with Breakthrough Psychedelics Today!

Enroll in the course and get access to materials forever or access this course and a library of other psychedelic pharmacology courses, webinars, and written guides along with consultation services with the Spirit Pharmacist Member Resource and Support Program

Forever Access

$147

Ala Carte

On demand and yours forever
Ability for live interaction or individualized consultation not included
30 days money back guarantee if not satisfied

Enroll in Course

Member Program

$99/m